Serum makers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis

Peritoneal Dialysis International

Volumn 26, Issue 1, 2006, Pages 78-84

  Ávila Díaz, Marcela ^a   Matos, Mario ^b   García López, Elvia ^b   Prado, María del Carmen ^a   Castro Vázquez, Florencia ^b   Ventura, María de Jesús ^a   González, Elia ^a   Amato, Dante ^a   Paniagua, Ramón ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Adynamic bone disease; Aluminum; Blood pressure; Children; Chronic kidney disease; Growth; Low turnover bone disease

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ALUMINUM; BIOCHEMICAL MARKER; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CHOLESTEROL; CREATININE; DIANEAL; GLUCOSE; NATURALYTE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PHOSPHORUS; TRIACYLGLYCEROL; UREA; BIOLOGICAL MARKER;

ADOLESCENT; AGE DISTRIBUTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ALUMINUM BLOOD LEVEL; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DISEASE; BONE TURNOVER; CALCIUM BLOOD LEVEL; CHILD; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIALYSATE; DIALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH DISORDER; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MALE; MEXICO; OUTPATIENT CARE; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PHOSPHATE BLOOD LEVEL; PRESCRIPTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; FOLLOW UP; INCIDENCE; MULTICENTER STUDY; PRESCHOOL CHILD; RENAL OSTEODYSTROPHY;

ADOLESCENT; BIOLOGICAL MARKERS; CALCIUM; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MEXICO; PARATHYROID HORMONE; RENAL DIALYSIS; RENAL OSTEODYSTROPHY;

EID: 33745475198     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600112     Document Type: Article

References (41)

1. K/DOQI. NKF. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(Suppl 3):S1-S201.
2. Fournier A, Oprisiu R, Hotterlat C, Yverneau PH, Ghazali A, Atik A, et al. Renal osteodystrophy in dialysis patients: diagnosis and treatment. Artif Organs 1998; 22:530-57.
3. Goodman W, Coburn J, Slatopolsky E, Salusky I. Renal osteodystrophy in adults and children. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 1999: 347-63.
4. Hercz G, Pei Y, Greenwood C, Manuel A, Saiphoo C, Goodman WG, et al. Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function. Kidney Int 1993; 44:860-6.
5. Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, et al. Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 1998; 53:205-11.
6. Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000; 36:1115-21.
7. Hutchinson AJ, Whitehouse RW, Freemont AJ, Mawer EB, Gokal R. Histological, radiological and biochemical features of the adynamic lesion in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1994; 14: 19-29.
8. Osorio A, Seidel FG, Warady BA. Hypercalcemia and pancreatitis in a child with adynamic bone disease. Pediatr Nephrol 1997; 11:223-5.
9. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, et al. The spectrum of bone diseasein end-stage renal failure-an evolving disorder. Kidney Int 1993; 43: 436-42.
10. Sanchez CP. Prevention and treatment of renal osteodystrophy in children with chronic renal insufficiency and end-stage renal disease. Semin Nephrol 2001; 21:441-50.
11. Llach F, Fernández E. Overview of renal bone disease: causes of treatment failure, clinical observations, the changing pattern of bone lesions, and future therapeutic approach. Kidney Int Suppl 2003; 87:S113-19.
12. Qi Q, Mounier-Faugere MC, Geng Z, Maluche H. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 1995; 26:622-31.
13. Ferreira A. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy: what do we have, what do we need? Nephrol Dial Transplant 1998; 13(Suppl 3): 29-32.
14. Jarava C, Armas JR, Palma A. Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers [in Spanish]. Nefrología 2000; 20:362-72.
15. Coen G, Ballanti P, Bonucci E, Calabria S, Costantini S, Ferrannini M, et al. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron 2002; 91:103-11.
16. Salusky IB, Ramírez JA, Opphenheim WL, Gales B, Segre GV, Goodman WG. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 1994; 45:253-8.
17. Mathias R, Salusky I, Harman W, Paredes A, Emans J, Segre G, et al. Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital. J Am Soc Nephrol 1993; 3:1938-46.
18. Ramos-Galvan R. Somatometría pediátrica. Arch Invest Med (Mex) 1975; 6(Suppl 1):83-396.
19. Sanchez CP. Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment. Paediatr Drugs 2003; 5:763-76.
20. Ziolkowska H, Paniczyk-Tomaszewska M, Debinski A, Polowiec Z, Sawicki A, Sieniawska M. Bone biopsy results and serum bone turnover parameters in uremic children. Acta Paediatr 2000; 89:666-71.
21. Yalcincaya F, Ince E, Turner N, Ensari A, Ozkaya N. Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis. Pediatr Int 2000; 42:53-7.
22. Gal-Moscovici A, Popovtzer MM. Parathyroid hormone-independent osteoclastic resorptive bone disease: a new variant of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant 2002; 17:620-4.
23. Cano FJ, Valenzuela M, Zambrano P, Azocar MA, Wolff E, Delucchi MA, et al. Renal osteodystrophy in pediatric patients on peritoneal dialysis. Adv Perit Dial 2004; 20: 237-44.
24. Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zaharanik RJ, Gales B, et al. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 2003; 63:1801-8.
25. Sieniawska M, Roszkowska-Blaim M, Wojciechowska B. The influence of dialysate calcium concentration on the PTH level in children undergoing CAPD. Perit Dial Int 1996; 16(Suppl 1):S567-9.
26. Schroder CH. European Paediatric Peritoneal Dialysis Working Group. The choice of dialysis solutionsin pediatric chronic peritoneal dialysis: guidelines by an ad hoc European committee. Perit Dial Int 2001; 21:568-74.
27. Kausz AT, Antonsen JE, Hercz G, Pei Y, Weiss NS, Emerson S, et al. Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients. Am J Kidney Dis 1999; 34:688-93.
28. Fernández-Martín JL, Canteros A, Alles A, Massari P, Cannata A. Aluminum exposure in chronic renal failure in Iberoamérica at the end of 1990s: overview and perspectives. Am J Med Sci 2000; 320:96-9.
29. Cannata BJ, Douthat W, Acuña-Aguerre G. Aluminium toxicity: the role of prevention. Life Chemistry Reports 1994; 11:207-13.
30. Jorgetti V, Lopez BD, Caorsi H, Ferreira A, Palma A, Menendez P, et al. Different patterns of renal osteodystrophy in Iberoamerica. Am J Med Sci 2000; 320:76-80.
31. Piscitelli J, Cabansag MR, Silverstein DM. Correlation among markers of renal osteodystrophy in pediatric hemodialysis patients. J Pediatr Endocrinol Metab 1999; 12: 879-86.
32. Sanchez CP, He YZ. Growth hormone therapy in calcium-loaded rats with renal failure. Endocrinology 2004; 145: 3375-85.
33. Powell DR, Liu F, Baker BK, Hintz RL, Lee PD, Durham SK, et al. Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group. Kidney Int 1997; 51: 1970-9.
34. Tonshoff B, Cronin MJ, Reichert M, Haffner D, Wingen AM, Blum WF, et al. Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. J Clin Endocrinol Metab 1997; 82:1007-13.
35. Fernström A, Hylander B, Moritz A, Jacobsson H, Rösner S. Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1998; 18:166-71.
36. Stenvinkel P, Lindholm B, Lönnqvist F, Katzarski K, Heimbürger O. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000; 11: 1303-9.
37. Jager KJ, Merkus MP, Huisman RM, Boeschoten EW, Dekker FW, Korevaar JC, et al. Nutritional status over time in hemodialysis and peritoneal dialysis. J Am Soc Nephrol 2001; 12:1272-9.
38. Kamycheva E, Sundsjford J, Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study. Eur J Cardiovasc Prev Rehabil 2004; 11:69-74.
39. Saleh FN, Schirmer H, Sundsfjord J, Jorde R. Parathyroid hormone and left ventricutar hypertrophy. Eur Heart J 2003; 24:2054-60.
40. Jespersen B, Randlov A, Abrahamsen J, Fogh-Andersen N, Kanstrup IL. Effect of PTH (1-34) on blood pressure, renal function and hormones in essential hypertension: the altered pattern of reactivity may counteract raised blood pressure. Am J Hypertens 1997; 10:1356-67.
41. Abdelfatah AB, Motte G, Ducloux D, Chalopin JM. Determinants of mean arterial pressure and pulse pressure in chronic hemodialysis patients. J Hum Hypertens 2001; 15: 775-9.